George, Tracy I.

Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal

Valent, P., Akin, C., Hartmann, K., Alvarez-Twose, I., Brockow, K., Hermine, O., Niedoszytko, M., Schwaab, J., Lyons, J. J., Carter, M. C., et al. (2021) · HemaSphere

Mast cells and histamineGastrointestinal Tumor Research and Treatment

Cited by 317

Altered translation of GATA1 in Diamond-Blackfan anemia

Ludwig, L. S., Gazda, H. T., Eng, J. C., Eichhorn, S. W., Thiru, P., Ghazvinian, R., George, T. I., Gotlib, J. R., Beggs, A. H., Sieff, C. A., et al. (2014) · Nature Medicine

Blood disorders and treatmentsRNA and protein synthesis mechanisms

Cited by 302

Global classification of mast cell activation disorders: an ICD-10-CM–adjusted proposal of the ECNM-AIM Consortium

Valent, P., Hartmann, K., Bonadonna, P., Gülen, T., Brockow, K., Alvarez-Twose, I., Hermine, O., Niedoszytko, M., Carter, M. C., Hoermann, G., et al. (2022) · The Journal of Allergy and Clinical Immunology: In Practice

Mast cells and histamineAsthma and respiratory diseases

Cited by 90

Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review

Gülen, T., Akin, C., Bonadonna, P., Siebenhaar, F., Broesby-Olsen, S., Brockow, K., Niedoszytko, M., Nedoszytko, B., Oude Elberink, H. N. G., Butterfield, J. H., et al. (2021) · The Journal of Allergy and Clinical Immunology: In Practice

Mast cells and histamineFood Allergy and Anaphylaxis Research

Cited by 83

Avapritinib versus placebo in indolent systemic mastocytosis

Gotlib, J., Castells, M., Elberink, H. O., Siebenhaar, F., Hartmann, K., Broesby-Olsen, S., George, T. I., Panse, J., Alvarez-Twose, I., Radia, D. H., et al. (2023) · NEJM Evidence

Mast cells and histamineGastrointestinal Tumor Research and Treatment

Cited by 81

Midostaurin: a magic bullet that blocks mast cell expansion and activation

Valent, P., Akin, C., Hartmann, K., George, T. I., Sotlar, K., Peter, B., Gleixner, K. V., Blatt, K., Sperr, W. R., Manley, P. W., et al. (2017) · Annals of Oncology

Mast cells and histamineGastrointestinal Tumor Research and Treatment

Cited by 79

Personalized management strategies in mast cell disorders: ECNM-AIM user’s guide for daily clinical practice

Valent, P., Hartmann, K., Schwaab, J., Alvarez-Twose, I., Brockow, K., Bonadonna, P., Hermine, O., Niedoszytko, M., Carter, M. C., Hoermann, G., et al. (2022) · The Journal of Allergy and Clinical Immunology: In Practice

Mast cells and histamineGastrointestinal Tumor Research and Treatment

Cited by 72

The international consensus classification of mastocytosis and related entities

Leguit, R. J., Wang, S. A., George, T. I., Tzankov, A., & Orazi, A. (2023) · Virchows Archiv

Mast cells and histamineHistiocytic Disorders and Treatments

Cited by 65

Patient perceptions in mast cell disorders

Jennings, S. V., Slee, V. M., Zack, R. M., Verstovsek, S., George, T. I., Shi, H., Lee, P., & Castells, M. C. (2018) · Immunology and Allergy Clinics of North America

Mast cells and histamineFood Allergy and Anaphylaxis Research

Cited by 53

Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium

Pyatilova, P., Akin, C., Alvarez-Twose, I., Arock, M., Bonadonna, P., Brockow, K., Butterfield, J. H., Broesby-Olsen, S., Carter, M. C., Castells, M., et al. (2022) · The Journal of Allergy and Clinical Immunology In Practice

Mast cells and histamineGastrointestinal Tumor Research and Treatment

Cited by 27

Increased Detection of KIT D816V Mutation in Peripheral Blood Samples from Patients with Indolent Systemic Mastocytosis (ISM) in the Phase 2 Pioneer Study Using a High Sensitivity Droplet Digital (dd) PCR Assay Compared with Next Generation Sequencing (NGS)

George, T. I., Hoehn, G., Lin, H.-M., Miller, S., & Akin, C. (2020) · Blood

Mast cells and histamineGastrointestinal Tumor Research and Treatment

Cited by 10